.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Citi
Colorcon
Accenture
Express Scripts
Merck
Cerilliant
Mallinckrodt
Cipla
Medtronic

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201451

« Back to Dashboard
NDA 201451 describes MECLIZINE HYDROCHLORIDE, which is a drug marketed by Superpharm, Vangard, Kv Pharm, Par Pharm, Pliva, Mylan Pharms Inc, Watson Labs, Sandoz, Amneal Pharms, Abc Holding, UDL, Ani Pharms Inc, Jubilant Cadista, Bundy, Ivax Sub Teva Pharms, Rising Pharms Inc, Anabolic, Nexgen Pharma Inc, and Epic Pharma Llc, and is included in thirty-four NDAs. It is available from thirty-eight suppliers. Additional details are available on the MECLIZINE HYDROCHLORIDE profile page.

The generic ingredient in MECLIZINE HYDROCHLORIDE is meclizine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the meclizine hydrochloride profile page.

Summary for NDA: 201451

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antiemetics
Formulation / Manufacturing:see details

Pharmacology for NDA: 201451

Physiological EffectEmesis Suppression

Suppliers and Packaging for NDA: 201451

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MECLIZINE HYDROCHLORIDE
meclizine hydrochloride
TABLET;ORAL 201451 ANDA Major Pharmaceuticals 0904-6516 0904-6516-61 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0904-6516-61) > 1 TABLET in 1 BLISTER PACK
MECLIZINE HYDROCHLORIDE
meclizine hydrochloride
TABLET;ORAL 201451 ANDA Major Pharmaceuticals 0904-6517 0904-6517-61 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0904-6517-61) > 1 TABLET in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength12.5MG
Approval Date:Feb 23, 2011TE:AARLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Feb 23, 2011TE:AARLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG
Approval Date:Feb 23, 2011TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
US Army
McKesson
Cantor Fitzgerald
Julphar
Deloitte
Colorcon
Federal Trade Commission
Dow
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot